In 2002, Scott Dylla, a skinny postdoc with a Minnesota accent, answered a Craigslist ad for a room for rent in Palo Alto. Although he couldn’t afford to move in with Brian Slingerland, then an up-and-coming technology banker at Credit Suisse, the two got to talking.
Two of Slingerland’s aunts had died of cancer. One, only a year after she retired. The other of lung cancer. She’d always smoked Kents.
{iframe}http://www.technologyreview.com/news/541006/peter-thiel-backs-biotech-unicorn-fighting-cancer-stem-cells/?utm_campaign=newsletters&utm_source=newsletter-daily-all&utm_medium=email&utm_content=20150908{/iframe}